Synthesis of next generation dual-responsive cross-linked nanoparticles and their application to anti-cancer drug delivery
Source abstract
Abstract
Rare earth metal-mediated group transfer polymerisation enables the synthesis of previously inaccessible block copolymers of 2-vinylpyridine, diethyl vinylphosphonate and the new diallyl vinylphosphonate monomer. This precision polymerisation and the selective cross-linking of allyl side groups via thiol-ene click chemistry leads to the formation of well-defined dual-responsive nanoparticles. We demonstrate that these next generation nanocarriers are pH- and temperature-responsive and are capable of efficiently delivering doxorubicin into the nucleus of cancer cells. High anti-cancer activity could be demonstrated via cytotoxicity tests on breast cancer (MCF-7) and cervical cancer (HeLa) cells. These results validate this modular synthesis route as an ideal platform for the development of sophisticated nanocarriers for future drug delivery applications.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
WACKER Lehrstuhl für Makromolekulare Chemie
Technische Universität München
85748 Garching bei München
Germany
Medizinische Klinik und Poliklinik IV
Nephrologisches Zentrum und Arbeitsgruppe Klinische Biochemie
University of Munich
Munich
Definiens AG
80636 Munich
References (55)
Show source-provided references
1. Chen · J. Controlled Release · 2015 · 210 · 12510.1016/j.jconrel.2015.05.273 ↗
2. Fojo · JNCI J. Natl Cancer Inst. · 2009 · 101 · 104410.1093/jnci/djp177 ↗
3. Tol · N. Engl. J. Med. · 2009 · 360 · 56310.1056/NEJMoa0808268 ↗
4. Shim · Adv. Drug Delivery Rev. · 2012 · 64 · 104610.1016/j.addr.2012.01.018 ↗
5. Zhuang · Chem. Soc. Rev. · 2013 · 42 · 742110.1039/c3cs60094g ↗
6. Mura · Nat. mater. · 2013 · 12 · 99110.1038/nmat3776 ↗
7. Peer · Nat. Nanotechnol. · 2007 · 2 · 75110.1038/nnano.2007.387 ↗
8. Davis · Nat. Rev. Drug Discovery · 2008 · 7 · 77110.1038/nrd2614 ↗
9. Bae · Adv. Drug Delivery Rev. · 2009 · 61 · 76810.1016/j.addr.2009.04.016 ↗
10. Cheng · Biomaterials · 2013 · 34 · 364710.1016/j.biomaterials.2013.01.084 ↗
11. Alshememry · Curr. Pharm. Des. · 2017 · 5358
12. Matsumura · Cancer Sci. · 2009 · 100 · 57210.1111/j.1349-7006.2009.01103.x ↗
13. Duncan · Nat. Rev. Drug Discovery · 2003 · 2 · 34710.1038/nrd1088 ↗
14. Vicent · Adv. Drug Delivery Rev. · 2009 · 61 · 111710.1016/j.addr.2009.08.001 ↗
15. Maeda · Adv. Drug Delivery Rev. · 2001 · 46 · 16910.1016/S0169-409X(00)00134-4 ↗
16. J. Fang , T.Sawa and H.Maeda , in Polymer Drugs in the Clinical Stage , Springer , 2004 , pp. 29–49
17. Ding · Polym. Chem. · 2013 · 4 · 334510.1039/c3py00144j ↗
18. Abulateefeh · Biomater. Sci. · 2013 · 1 · 43410.1039/c2bm00184e ↗
19. Fang · Adv. Drug Delivery Rev. · 2011 · 63 · 13610.1016/j.addr.2010.04.009 ↗
20. Meng · Mater. Today · 2012 · 15 · 43610.1016/S1369-7021(12)70195-5 ↗
21. Deng · Nano Today · 2012 · 7 · 46710.1016/j.nantod.2012.08.005 ↗
22. Stirland · J. Controlled Release · 2013 · 172 · 104510.1016/j.jconrel.2013.09.026 ↗
23. Barenholz · J. Controlled Release · 2012 · 160 · 11710.1016/j.jconrel.2012.03.020 ↗
24. Kashyap · Biomacromolecules · 2016 · 17 · 38410.1021/acs.biomac.5b01545 ↗
25. Ge · Chem. Soc. Rev. · 2013 · 42 · 728910.1039/c3cs60048c ↗
26. Li · Biomacromolecules · 2014 · 15 · 291410.1021/bm500532x ↗
27. Chen · Biomaterials · 2013 · 34 · 450110.1016/j.biomaterials.2013.02.049 ↗
28. Issels · JAMA Oncol. · 2018 · 4 · 48310.1001/jamaoncol.2017.4996 ↗
29. Wu · Chem. Commun. · 2011 · 47 · 1127610.1039/c1cc14627k ↗
30. Nilsson · Methods Cell Sci. · 2004 · 25 · 18510.1007/s11022-004-8228-3 ↗
31. Fang · Expert Opin. Drug Delivery · 2015 · 12 · 194310.1517/17425247.2015.1071352 ↗
32. Haag · Angew. Chem., Int. Ed. · 2006 · 45 · 119810.1002/anie.200502113 ↗
33. Pietsch · Angew. Chem., Int. Ed. · 2009 · 48 · 565310.1002/anie.200901071 ↗
34. Qu · Nanoscale · 2014 · 6 · 1240810.1039/C4NR03384A ↗
35. Zha · Soft Matter · 2011 · 7 · 590810.1039/c0sm01307b ↗
36. Roux · Int. J. Pharm. · 2002 · 242 · 2510.1016/S0378-5173(02)00183-7 ↗
37. Lutz · J. Am. Chem. Soc. · 2006 · 128 · 1304610.1021/ja065324n ↗
38. Altenbuchner · Chem. – Eur. J. · 2016 · 22 · 1457610.1002/chem.201601822 ↗
39. Rigger · Chem. – Eur. J. · 2013 · 19 · 1587210.1002/chem.201302188 ↗
40. Soller · Organometallics · 2015 · 34 · 270310.1021/om501173r ↗
41. Matsumura · Cancer Res. · 1986 · 46 · 6387
42. Wang · ACS Nano · 2015 · 9 · 719510.1021/acsnano.5b02017 ↗
43. Elul · J. Physiol. · 1967 · 189 · 35110.1113/jphysiol.1967.sp008173 ↗
44. Musyanovych · Acta Biomater. · 2011 · 7 · 416010.1016/j.actbio.2011.07.033 ↗
45. Fröhlich · Int. J. Nanomed. · 2012 · 7 · 557710.2147/IJN.S36111 ↗
46. Nakamura · Biochem. Biophys. Res. Commun. · 1998 · 245 · 23510.1006/bbrc.1998.8334 ↗
47. Campbell · Cancer Res. · 2002 · 62 · 6831
48. Zhao · Int. J. Nanomed. · 2011 · 6 · 3087
49. Li · Mol. Pharm. · 2008 · 5 · 49610.1021/mp800049w ↗
50. Kim · Pharm. Res. · 2009 · 26 · 115510.1007/s11095-009-9835-0 ↗
51. Li · Colloids Surf., B · 2015 · 132 · 5410.1016/j.colsurfb.2015.04.066 ↗
52. Nikolaou · Clin. Exp. Metastasis · 2018 · 1
53. Robey · Nat. Rev. Cancer · 2018 · 1
54. McIntosh · Expert Opin. Drug Metab. Toxicol. · 2016 · 12 · 63310.1080/17425255.2016.1179280 ↗
55. Wang · Int. J. Clin. Exp. Pathol. · 2014 · 7 · 1337